David J.  Schlanger net worth and biography

David Schlanger Biography and Net Worth

Executive Chairman of Progyny

David brings over 25 years of healthcare and executive management experience to the company. During his tenure as CEO, Progyny reached many key milestones, including achieving five consecutive years of industry leading clinical outcomes, becoming the first fertility and family building company to go public, being added to the prestigious S&P 400 index, and significantly growing its clients and covered lives. Prior to joining Progyny, David was the CEO of WebMD.

What is David J. Schlanger's net worth?

The estimated net worth of David J. Schlanger is at least $4.88 million as of December 26th, 2024. Mr. Schlanger owns 228,269 shares of Progyny stock worth more than $4,884,957 as of April 16th. This net worth approximation does not reflect any other investments that Mr. Schlanger may own. Additionally, Mr. Schlanger receives an annual salary of $513,570.00 as Executive Chairman at Progyny. Learn More about David J. Schlanger's net worth.

How old is David J. Schlanger?

Mr. Schlanger is currently 65 years old. There are 4 older executives and no younger executives at Progyny. Learn More on David J. Schlanger's age.

What is David J. Schlanger's salary?

As the Executive Chairman of Progyny, Inc., Mr. Schlanger earns $513,570.00 per year. There are 4 executives that earn more than Mr. Schlanger. The highest earning executive at Progyny is Mr. Peter Anevski, CEO & Director, who commands a salary of $1,090,000.00 per year. Learn More on David J. Schlanger's salary.

How do I contact David J. Schlanger?

The corporate mailing address for Mr. Schlanger and other Progyny executives is 1359 BROADWAY, NEW YORK NY, 10018. Progyny can also be reached via phone at 212-888-3124 and via email at investors@progyny.com. Learn More on David J. Schlanger's contact information.

Has David J. Schlanger been buying or selling shares of Progyny?

David J. Schlanger has not been actively trading shares of Progyny during the last quarter. Most recently, on Thursday, December 26th, David J. Schlanger bought 150,000 shares of Progyny stock. The stock was acquired at an average cost of $14.68 per share, with a total value of $2,202,000.00. Following the completion of the transaction, the chairman now directly owns 228,269 shares of the company's stock, valued at $3,350,988.92. Learn More on David J. Schlanger's trading history.

Who are Progyny's active insiders?

Progyny's insider roster includes Peter Anevski (COO), Jennifer Bealer (EVP), Kevin Gordon (Director), Lisa Greenbaum (EVP), Mark Livingston (CEO), Norman Payson (Director), David Schlanger (Executive Chairman), Cheryl Scott (Director), and Michael Sturmer (President). Learn More on Progyny's active insiders.

Are insiders buying or selling shares of Progyny?

In the last twelve months, Progyny insiders bought shares 2 times. They purchased a total of 359,500 shares worth more than $5,235,560.00. In the last twelve months, insiders at the sold shares 3 times. They sold a total of 15,007 shares worth more than $456,660.43. The most recent insider tranaction occured on December, 26th when Chairman David J Schlanger bought 150,000 shares worth more than $2,202,000.00. Insiders at Progyny own 12.3% of the company. Learn More about insider trades at Progyny.

Information on this page was last updated on 12/26/2024.

David J. Schlanger Insider Trading History at Progyny

David J. Schlanger Buying and Selling Activity at Progyny

This chart shows David J Schlanger's buying and selling at Progyny by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$5M$0$5MTotal Insider BuyingTotal Insider Selling

Progyny Company Overview

Progyny logo
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Read More

Today's Range

Now: $21.40
Low: $21.06
High: $21.75

50 Day Range

MA: $21.98
Low: $19.82
High: $23.88

2 Week Range

Now: $21.40
Low: $13.39
High: $33.84

Volume

1,423,098 shs

Average Volume

1,736,945 shs

Market Capitalization

$1.83 billion

P/E Ratio

36.90

Dividend Yield

N/A

Beta

1.33